We are delighted to share with you the launch of our website - pcostracker.app - for PCOS Tracker app that aims to help women specifically track their daily and monthly PCOS (Polycystic Ovary Syndrome) and PMS (Premenstrual Syndrome) symptoms. The PCOS Tracker has been downloaded nearly...
CureTalks launches its new series featuring biotech companies at the cutting edge of innovation and breakthrough research with the purpose of bringing their contributions to the fore and informing the patient community. This talk series will be hosted by Gary Petersen, our Myeloma talk...
CenterWatch iConnect’s clinical trial finder is now live on Rett Syndrome.org. The trial finder called myRett Trial Finder is part of a larger initiative called Rett Research Ready™ - an online platform that includes education, resources and support to help families consider volunteering for...
We are excited to announce that CureTalks has launched a new format with a talk series on Covid -19 in collaboration with the University of Pennsylvania. The new format moves away from the standard CureTalks radio pattern and introduces the panel on video. The talk series...
We recently went live with the latest TrialX iConnect release v4.2 on NYU Langone Medical Center which included enhanced account security by imposing strong password rules and SSO authentication for study team members. Enhanced Account Security iConnect allows participants to sign up as a volunteer and get...
In the latest release of V3.11, CenterWatch iConnect has been successfully integrated with Exostar - a key identity and SSO provider for large pharma companies and we are live with this feature on Pfizer. Integration with Exostar, involves subscribing a Site user (Investigators / Other site...
Survey questionnaires are powerful tools used by researchers and physicians who seek to enhance the quality of care delivered or collect data from patients and trial participants. However, these surveys can get quite complex with branching questions and sub-questions. Appbakery, our DIY...